Healthcare & Life Sciences
DENDROGENIX
Belgiumdendrogenix.com
DENDROGENIX is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About DENDROGENIX
Based in Belgium, DENDROGENIX is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Dendrogenix is a Belgian biopharmaceutical company developing first-in-class small molecule drugs called Dendrogenins that promote cell differentiation and induce growth of dendrites on dendritic and neuron precursors to treat hearing loss and neurological diseases.
Explore DENDROGENIX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.